Market Industry Reports (MIR) has published a new report

New Post Public Reply Private Reply Replies (0) Message Board
sam_7
559
Market Industry Reports (MIR) has published a new report titled “ Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global virus filtration market is estimated to be over US$ 600 Mn in 2018. It is anticipated to grow at a double digit CAGR from 2019 to 2030.

The continual increasing adoption of clinical trial management systems, to manage and process the rising number of clinical trials being conducted worldwide has presented a bright prospect for the growth of global clinical trial management systems market. Increasing funding for R&D, coupled with rising incidences of chronic disorders globally has further contributed to the significant growth of the clinical trial management systems market. However, budget constraints for purchase of clinical trial management systems, is likely to restrain the market to certain extent.

Get Free PDF Sample Copy @ https://www.marketindustryreports.com/pdf/49

Increasing Number of Clinical Trials

Rapid increase in geriatric population, and growing prevalence of chronic disorders worldwide has played a pivotal role in contributing to the increasing number of clinical trials conducted every year. Moreover, availability of funds for clinical trials, expiry of patents for several drugs and fierce competition in the pharmaceutical industry has contributed extensively to the growth of clinical trials. The growing number clinical trials has directly resulted in the wide scale adoption of clinical trial management systems worldwide to better process and manage such trials with high degree of simplicity and efficiency.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Clinical Trial Management System Market by Type (Site, Enterprise), Delivery Mode (Web-based (Hosted), Cloud-based (SaaS), Licensed Enterprise (On Premise)), Component  (Services, Software), End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations) and Region - Global Analysis & Forecast, 2019-2030  in detail along with the table of contents: https://www.marketindustryreports.com/49/clin...tem-market

Increasing Investments in R&D

Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques, and ideas to obtain latest medical breakthroughs. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by governmental establishments as well as major market players and other research institutes. Increasing R&D investments and funding for clinical trials is anticipated to positively contribute to the growth of the global clinical trial management systems market.

High Costs of Clinical Trial Management Systems to Restrain the Market

High costs associated with clinical trial management systems are one of the major factors affecting the prosperous growth of the global clinical trial management systems market. Budget constraints, lack of necessary infrastructure faced by startups and other small-to-medium-sized enterprises (SMEs) for purchase of clinical trial management systems for efficient segregation and maintenance of patient data has contributed to the limited adoption of these systems globally. Clinical trial management systems are expensive and require enormous amount of capital investment for implementation, hence these factors are considered to be the major hindrances in the growth of the global clinical trial management systems market.

Rapid Growth of the Asia Pacific Market

Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing growth of the biopharmaceutical industry, continuously growing economy, and increasing burden of chronic diseases, presence of diverse patient base for clinical trials is anticipated to present a lucrative growth scenario for the clinical trial management systems market in this region. Furthermore, improving research facilities, favorable government regulations coupled with increasing R&D expenditures in the region is expected to present an attractive growth prospect for the market in the coming years.   

Major Players in the Virus Filtration Market

The prominent players in the global virus filtration market are Oracle, Parexel, Bio-Optronics, IBM, Bioclinica, Medidata, Mednet Solutions, Veeva Systems, Mastercontrol and DZS Clinical Services among others.

Get Exclusive Discount @ https://www.marketindustryreports.com/discount/49

About Market Industry Reports-

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us- 


502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook

Correvio Pharma Corp (CORV) Stock Research Links

CORV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading